BNR
Burning Rock Biotech
$12.26
+$0.39 (+3.29%)Oct 28, 2026
Key metrics
The numbers that frame BNR today
- Market cap
- $133.15M
- Gross margin
- 74.6%
- EV / Sales
- 1.0
- ROIC
- -44.5%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $6.79
- 52wk High
- $41.72
Growth
Revenue and earnings trend for BNR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BNR
Is Burning Rock Biotech a good buy?
Yes. Burning Rock Biotech has strong quality and excellent momentum. Both signals support the setup. Growth looks poor, a caveat that does not overturn the setup. We think Burning Rock Biotech is selling at a high price, which cuts against the buy case.
What is the market capitalization of BNR?
Burning Rock Biotech's market capitalization is $133.15M.
What is the 52-week high for BNR stock?
The 52-week high for Burning Rock Biotech is $41.72. The current close of $12.26 is 70.6% below that high.
What is the 52-week low for BNR stock?
The 52-week low for Burning Rock Biotech is $6.79. The current close of $12.26 is 80.6% above that low.
Does BNR stock pay dividends?
Burning Rock Biotech does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BNR?
Burning Rock Biotech's Debt / Equity ratio is 0.09.